An acute rheumatic fever immune signature comprising inflammatory markers, IgG3, and Streptococcus pyogenes-specific

Natalie Lorenz1,2, Reuben McGregor1,2, Alana L Whitcombe1,2

  • 1School of Medical Science, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.

Iscience
|August 26, 2024
PubMed

Insights

Acute rheumatic fever (ARF) is linked to heightened group A Streptococcus (GAS) antibody responses, particularly IgG3. This immune profile, including inflammatory cytokines, may aid in ARF diagnosis and understanding its pathogenesis.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Rheumatology

Background:

  • Acute rheumatic fever (ARF) is a significant post-infectious complication of group A Streptococcus (GAS) infection.
  • Understanding the immune mechanisms of ARF is crucial for improving disease management and pathogenesis insights.

Purpose of the Study:

  • To characterize the circulating immune profile in patients with first-episode ARF.
  • To compare immune responses in ARF, GAS pharyngitis, and healthy controls.
  • To investigate the role of specific antibody subclasses and inflammatory markers in ARF.

Main Methods:

  • Analysis of circulating cytokines, immunoglobulins (including IgG subclasses), and complement components.
  • Quantification of GAS-specific antibody responses.
  • Comparison between patients with ARF, GAS pharyngitis, and healthy controls.

Main Results:

  • Elevated total IgG3 levels were observed in 90% of ARF patients.
  • ARF was associated with an inflammatory triad (interleukin-6, C-reactive protein, complement C4).
  • GAS-specific antibody responses, particularly IgG3 to M-protein, were significantly higher in ARF patients.

Conclusions:

  • Exaggerated group A Streptococcus antibody responses, specifically IgG3, and inflammatory cytokines are associated with ARF.
  • IgG3 testing may serve as a valuable adjunct for clinical diagnosis of ARF.
  • Immune profiling provides insights into ARF pathogenesis.